These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides: pathophysiology and emerging therapies. Duvic M; Foss FM Semin Oncol; 2007 Dec; 34(6 Suppl 5):S21-8. PubMed ID: 18086343 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma. Whittaker SJ; Foss FM Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. Devata S; Wilcox RA Am J Clin Dermatol; 2016 Jun; 17(3):225-37. PubMed ID: 26923912 [TBL] [Abstract][Full Text] [Related]
6. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome. Zic JA Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848 [TBL] [Abstract][Full Text] [Related]
7. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006 [TBL] [Abstract][Full Text] [Related]
8. Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting. Reddy SA Crit Rev Oncol Hematol; 2016 Oct; 106():99-107. PubMed ID: 27637355 [TBL] [Abstract][Full Text] [Related]
9. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. Ramelyte E; Dummer R; Guenova E Expert Opin Investig Drugs; 2019 Sep; 28(9):799-809. PubMed ID: 31398295 [No Abstract] [Full Text] [Related]
10. Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. Foss F; Duvic M; Lerner A; Waksman J; Whittaker S Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):637-643. PubMed ID: 27637428 [TBL] [Abstract][Full Text] [Related]
11. Overview of Cutaneous T-Cell Lymphomas. Larocca CA; LeBoeuf NR Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162 [TBL] [Abstract][Full Text] [Related]
12. Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome. Mehra T; Ikenberg K; Moos RM; Benz R; Nair G; Schanz U; Haralambieva E; Hoetzenecker W; Dummer R; French LE; Guenova E; Cozzio A JAMA Dermatol; 2015 Jan; 151(1):73-7. PubMed ID: 25317818 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms. Dummer R; Foss F; Dreno B; Bagot M Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673 [TBL] [Abstract][Full Text] [Related]